secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001437749-23-034146
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences declares warrant distribution; holders get 4 warrants per 10 shares, exercise price $33
--------------------------------------------------------------------------------

- Stockholders of record Dec 22, 2023 receive 4 warrants per 10 shares, free of charge; distributed Jan 3, 2024.
- Each warrant exercisable for one share at $33; warrants expected to trade on Nasdaq under ticker 'SAVAW'.
- Early exercise before Bonus Share Expiration yields additional 0.5 common share per warrant, effective price ~$22.
- Warrants expire Nov 15, 2024; redeemable by company after Apr 15, 2024 on 20 days' notice.
- Proceeds from warrant exercises to fund Phase 3 clinical trials of oral simufilam for Alzheimer's disease.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774923034146/0001437749-23-034146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774923034146/sava20231211_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-034146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer